Advocacy intelligence hub — real-time data for patient organizations
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. — PHASE1
Tata Memorial Centre — PHASE2
National Cancer Institute (NCI) — PHASE1
University Hospital, Caen
Tata Memorial Centre — PHASE2
Neonc Technologies, Inc. — PHASE1, PHASE2
German Cancer Research Center — PHASE1
Henan Provincial People's Hospital
National Cancer Institute (NCI) — PHASE2
National Cancer Institute (NCI) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Maryam Fouladi, MD, MD
Nationwide Children's Hospital
📍 COLUMBUS, OH
Sabine Mueller, MD, PhD
University of California, San Francisco
📍 Birmingham, Alabama
Sani H Kizilbash, M.B.B.S
Mayo Clinic Cancer Center LAO
📍 ROCHESTER, MN
Debra N Yeboa, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Sabine Mueller, MD, PhD, MAS, MD, PhD
University of California, San Francisco
📍 SAN FRANCISCO, CA
Patrick Wen, MD, MD
National Cancer Institute (NCI)
📍 BOSTON, MA